Plain-English translation of NCT04579900 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand how bacteria in your gut may play a role in type 2 diabetes. This study will collect small tissue samples from your upper intestine (duodenum) and stool samples from your lower intestine, then compare the bacteria found in people with type 2 diabetes to those without it.
Animal studies suggest that in type 2 diabetes, bacteria may cross from the gut into the bloodstream and tissues, contributing to problems with blood sugar control. This study aims to find out if the same thing happens in humans and to identify which specific bacteria might be involved.
You likely qualify if…
You likely don't qualify if…
You will have two visits where researchers collect tissue samples from your upper intestine using a small biopsy procedure and a stool sample from your lower intestine. These samples will be analyzed to identify the bacteria present and compare the results between people with and without type 2 diabetes.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Canada
Sponsor
Laval University
Enrollment target
~40 participants
Started
February 2021
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 60 Years
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Geneviève Pilon, PhD
Laval University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.